132 related articles for article (PubMed ID: 15124772)
1. C1-inhibitor activity and plasma concentrations in patients with monoclonal gammopathies: implications for treatment with recombinant interferon-beta 1b.
Schmidt S; Schneider T; Schmidt-Wolf I; Ko Y; Schlegel U; Klockgether T; Hertfelder HJ
Mult Scler; 2004 Apr; 10(2):243-4. PubMed ID: 15124772
[No Abstract] [Full Text] [Related]
2. Lethal capillary leak syndrome after a single administration of interferon beta-1b.
Niederwieser G
Neurology; 2000 Apr; 54(7):1545-6. PubMed ID: 10751284
[No Abstract] [Full Text] [Related]
3. Panniculitis and lipoatrophy after subcutaneous injection of interferon beta-1b in a patient with multiple sclerosis.
O'Sullivan SS; Cronin EM; Sweeney BJ; Bourke JF; Fitzgibbon J
J Neurol Neurosurg Psychiatry; 2006 Dec; 77(12):1382-3. PubMed ID: 16782776
[No Abstract] [Full Text] [Related]
4. Arthritis during interferon beta-1b treatment in multiple sclerosis.
Altintas A; Alici Y; Melikoğlu M; Siva A
Mult Scler; 2002 Dec; 8(6):534-6. PubMed ID: 12474998
[TBL] [Abstract][Full Text] [Related]
5. Scleromyxedema in a patient with multiple sclerosis and monoclonal gammopathy on interferon beta-1a.
Kumar N; Rodriguez M
Mult Scler; 2004 Feb; 10(1):85-6. PubMed ID: 14760958
[TBL] [Abstract][Full Text] [Related]
6. Onset of myasthenia gravis in a patient with multiple sclerosis during interferon-1b treatment.
Blake G; Murphy S
Neurology; 1997 Dec; 49(6):1747-8. PubMed ID: 9409387
[No Abstract] [Full Text] [Related]
7. Autoantibodies in multiple sclerosis patients before and during IFN-beta 1b treatment: are they correlated with the occurrence of autoimmune diseases?
Verdun E; Isoardo G; Oggero A; Ferrero B; Ghezzi A; Montanari E; Zaffaroni M; Durelli L;
J Interferon Cytokine Res; 2002 Feb; 22(2):245-55. PubMed ID: 11911808
[TBL] [Abstract][Full Text] [Related]
8. Lethal capillary leak syndrome after a single administration of interferon beta-1b.
Schmidt S; Hertfelder HJ; von Spiegel T; Hering R; Harzheim M; Lassmann H; Deckert-Schlüter M; Schlegel U
Neurology; 1999 Jul; 53(1):220-2. PubMed ID: 10408566
[TBL] [Abstract][Full Text] [Related]
9. Acute acneiform eruption induced by interferon beta-1b during treatment for multiple sclerosis.
Rosa DJ; Matias Fde A; Cedrim SD; Machado RF; Sá AA; Silva VC
An Bras Dermatol; 2011; 86(2):336-8. PubMed ID: 21603818
[TBL] [Abstract][Full Text] [Related]
10. Abdominal wall ulceration and mucinosis secondary to recombinant human interferon-beta-1b.
Wells J; Kossard S; McGrath M
Australas J Dermatol; 2005 Aug; 46(3):202-4. PubMed ID: 16008658
[TBL] [Abstract][Full Text] [Related]
11. [Interferon beta-1b retinopathy during a treatment for multiple sclerosis].
Sommer S; Sablon JC; Zaoui M; Rozot P; Hosni A
J Fr Ophtalmol; 2001 May; 24(5):509-12. PubMed ID: 11397988
[TBL] [Abstract][Full Text] [Related]
12. Thrombotic microangiopathy induced by long-term interferon-β therapy for multiple sclerosis: a case report.
Broughton A; Cosyns JP; Jadoul M
Clin Nephrol; 2011 Nov; 76(5):396-400. PubMed ID: 22000560
[TBL] [Abstract][Full Text] [Related]
13. Interferon beta but not glatiramer acetate therapy aggravates headaches in MS.
Pöllmann W; Erasmus LP; Feneberg W; Then Bergh F; Straube A
Neurology; 2002 Aug; 59(4):636-9. PubMed ID: 12196668
[TBL] [Abstract][Full Text] [Related]
14. Optimization of the safety and efficacy of interferon beta 1b and azathioprine combination therapy in multiple sclerosis.
Pulicken M; Bash CN; Costello K; Said A; Cuffari C; Wilterdink JL; Rogg JM; Mills P; Calabresi PA
Mult Scler; 2005 Apr; 11(2):169-74. PubMed ID: 15794390
[TBL] [Abstract][Full Text] [Related]
15. Frequency and magnitude of interferon β neutralizing antibodies in the evaluation of interferon β immunogenicity in patients with multiple sclerosis.
Grossberg SE; Oger J; Grossberg LD; Gehchan A; Klein JP
J Interferon Cytokine Res; 2011 Mar; 31(3):337-44. PubMed ID: 21226608
[TBL] [Abstract][Full Text] [Related]
16. Interferon-beta treatment decreases cholesterol plasma levels in multiple sclerosis patients.
Morra VB; Coppola G; Orefice G; De Michele G; Vacca G; Filla A; Bonavita V
Neurology; 2004 Mar; 62(5):829-30. PubMed ID: 15007146
[No Abstract] [Full Text] [Related]
17. Acute hepatitis secondary to interferon beta-1a in multiple sclerosis.
Christopher V; Scolding N; Przemioslo RT
J Neurol; 2005 Jul; 252(7):855-6. PubMed ID: 15742101
[No Abstract] [Full Text] [Related]
18. Severe local skin reactions to interferon beta-1b in multiple sclerosis-improvement by deep subcutaneous injection.
Nakamura Y; Kawachi Y; Furuta J; Otsuka F
Eur J Dermatol; 2008; 18(5):579-82. PubMed ID: 18693165
[TBL] [Abstract][Full Text] [Related]
19. Cutaneous ulcerations and pustular psoriasis flare caused by recombinant interferon beta injections in patients with multiple sclerosis.
Webster GF; Knobler RL; Lublin FD; Kramer EM; Hochman LR
J Am Acad Dermatol; 1996 Feb; 34(2 Pt 2):365-7. PubMed ID: 8655728
[TBL] [Abstract][Full Text] [Related]
20. Liver and thyroid function and autoimmunity during interferon-beta 1b treatment for multiple sclerosis.
Tremlett H
Neurology; 2002 Jun; 58(12):1868. PubMed ID: 12084903
[No Abstract] [Full Text] [Related]
[Next] [New Search]
